Correlation Between Virios Therapeutics and Hepion Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virios Therapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virios Therapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virios Therapeutics Llc and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Virios Therapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virios Therapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virios Therapeutics and Hepion Pharmaceuticals.

Diversification Opportunities for Virios Therapeutics and Hepion Pharmaceuticals

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Virios and Hepion is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Virios Therapeutics Llc and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Virios Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virios Therapeutics Llc are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Virios Therapeutics i.e., Virios Therapeutics and Hepion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Virios Therapeutics and Hepion Pharmaceuticals

Given the investment horizon of 90 days Virios Therapeutics Llc is expected to generate 1.55 times more return on investment than Hepion Pharmaceuticals. However, Virios Therapeutics is 1.55 times more volatile than Hepion Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest  4,300  in Virios Therapeutics Llc on September 2, 2024 and sell it today you would lose (3,905) from holding Virios Therapeutics Llc or give up 90.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy92.47%
ValuesDaily Returns

Virios Therapeutics Llc  vs.  Hepion Pharmaceuticals

 Performance 
       Timeline  
Virios Therapeutics Llc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virios Therapeutics Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly uncertain basic indicators, Virios Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Hepion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hepion Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Virios Therapeutics and Hepion Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virios Therapeutics and Hepion Pharmaceuticals

The main advantage of trading using opposite Virios Therapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virios Therapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.
The idea behind Virios Therapeutics Llc and Hepion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets